VLS logo

Vita Life Sciences Limited Stock Price

ASX:VLS Community·AU$134.7m Market Cap
  • 1 Narratives written by author
  • 2 Comments on narratives written by author
  • 45 Fair Values set on narratives written by author
Create a narrative

VLS Share Price Performance

AU$2.45
0.24 (10.86%)
1.2% overvalued intrinsic discount
AU$2.42
Fair Value
AU$2.45
0.24 (10.86%)
1.2% overvalued intrinsic discount
AU$2.42
Fair Value
Price AU$2.45
Robbo AU$2.42

VLS Community Narratives

Robbo·
Fair Value AU$2.42 0% overvalued intrinsic discount

Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges

1users have liked this narrative
2users have commented on this narrative
30users have followed this narrative

Recent VLS News & Updates

Vita Life Sciences (ASX:VLS) Is Due To Pay A Dividend Of A$0.045

Aug 29
Vita Life Sciences (ASX:VLS) Is Due To Pay A Dividend Of A$0.045

Weekly Picks: 💊 VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns

Jun 17
Weekly Picks: 💊 VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns
User avatar

Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges

Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed MomentumVita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distribution

Improved Earnings Required Before Vita Life Sciences Limited (ASX:VLS) Shares Find Their Feet

Feb 21
Improved Earnings Required Before Vita Life Sciences Limited (ASX:VLS) Shares Find Their Feet

Vita Life Sciences Limited Key Details

AU$85.6m

Revenue

AU$34.0m

Cost of Revenue

AU$51.6m

Gross Profit

AU$42.3m

Other Expenses

AU$9.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.17
Gross Margin
60.34%
Net Profit Margin
10.88%
Debt/Equity Ratio
0%

Vita Life Sciences Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Flawless balance sheet established dividend payer.

1 Risk
2 Rewards
View Full Analysis

About VLS

Founded
1947
Employees
n/a
CEO
Andrew O'Keefe
WebsiteView website
vitalifesciences.com

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia.

Market Insight

Header cover image

📈 Markets Break Records: Q3 2025 in Review, Q4 Outlook Ahead

Richard Bowman avatarRichard Bowman
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Last Week
✨Rare Earths: Tiny Market, Outsized Influence

✨Rare Earths: Tiny Market, Outsized Influence

Australian Market Performance

  • 7 Days: -0.2%
  • 3 Months: 5.3%
  • 1 Year: 8.9%
  • Year to Date: 9.5%
In the last week, the market has been flat. As for the longer term, the market has risen 8.9% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›